Reuters logo
BRIEF-Leap Therapeutics reports qtrly net loss per share $1.39
2017年5月12日 / 上午11点04分 / 4 个月前

BRIEF-Leap Therapeutics reports qtrly net loss per share $1.39

May 12 (Reuters) - Leap Therapeutics Inc:

* Leap Therapeutics reports first quarter 2017 financial results

* Leap Therapeutics Inc - net loss was $9.4 million for Q1 of 2017, compared to $5.1 million for same period in 2016

* Leap Therapeutics Inc - cash, cash equivalents and marketable securities totaled $23.8 million at March 31, 2017

* Leap Therapeutics Inc qtrly net loss per share $1.39

* Leap Therapeutics Inc - research and development expenses were $6.4 million for Q1 2017, compared to $4.1 million for same period in 2016 Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below